Rethinking Beta-Blockers After a Heart Attack—Are They Still Safe for Women?
By: Dr. Bashar Obeidou and Nicole Roche
Beta-blockers, medications that slow the heart rate and lower blood pressure, have been a standard part of care after a heart attack for many years. But a new study is challenging that long-held practice, especially when it comes to women with preserved heart function.
What Did the New Research Find?
In the REBOOT clinical trial, of the more than 8,000 men and women who were observed, women taking beta-blockers after a heart attack had a 2.7 percent higher risk of death compared to women who didn’t take them during follow-up. Men didn’t show this effect. The increased risk was mainly seen in women whose heart function was normal after a heart attack. Women with only mild reduction in heart function didn’t have this increased risk when treated with beta-blockers.
What Could This Mean for Patients?
- Routine use of beta-blockers for everyone with preserved heart function may no longer be appropriate.
- For women with normal heart function after heart attacks, beta-blockers may carry real risks, including a slightly higher chance of death.
- However, for patients (men or women) with mildly reduced heart function, beta-blockers may still offer meaningful protection.
Why Is This Happening Now?
Advances in heart attack care, like faster artery reopening, better stents, and modern medications, have made beta-blockers less critical than in the past.
Key Takeaways
- Beta-blockers may not be needed as standard therapy for heart attack survivors with fully preserved heart function.
- Women constitute a special consideration; the potential for harm underscores the need for sex-specific treatment guidelines.
- The authors of the study say the women enrolled in the REBOOT trial were “generally older, sicker, and received less treatment for heart attacks than men.”
- Better personalization of care is vital, especially in deciding whether to prescribe beta-blockers after a heart attack.
If you’re taking beta-blockers, make sure to speak to your doctor before making any changes to your medication or your course of treatment. If you need to speak with a cardiologist, visit MiamiHeartLeader.org to make an appointment.
Bashar Obeidou, MD
Cardiovascular Disease, Interventional Cardiology
Jackson Medical Group
Jackson Heart Institute – Jackson South
9380 S.W. 150th St. Suite 295, Miami, Florida 33176